Benefits of Frequent HIV Testing in the THRIVE Demonstration Project: United States, 2015–2020
American Journal of Public Health · 2023
DOI: 10.2105/ajph.2023.307341 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Public Health, 2023. Verfasst von Anne A Kimball und 14 weiteren Autor:innen. Beteiligte Einrichtung: Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV …. Hauptthemen laut MEDLINE: HIV Infections, Sexual and Gender Minorities, Pre-Exposure Prophylaxis, Transgender Persons. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
To describe HIV testing among clients in the Targeted Highly Effective Interventions to Reverse the HIV Epidemic (THRIVE) demonstration project and evaluate testing frequency.
Methods
We identified factors associated with an average testing frequency of 180 days or less compared with more than 180 days using adjusted Poisson regression models. We performed the Kaplan–Meier survival analysis to compare time to diagnosis by testing frequency.
Results
Among 5710 clients with 2 or more tests and no preexposure prophylaxis (PrEP) prescription, 42.4% were tested frequently. Black/African American clients were 21% less likely and Hispanic/Latino clients were 18% less likely to be tested frequently than were White clients. Among 71 Black/African American and Hispanic/Latino cisgender men who have sex with men and transgender women with HIV diagnoses, those with frequent testing had a median time to diagnosis of 137 days, with a diagnostic testing yield of 1.5% compared with those tested less frequently, with 559 days and 0.8% yield.
Conclusions
HIV testing at least every 6 months resulted in earlier HIV diagnosis and was efficient. Persons in communities with high rates of HIV who are not on PrEP can benefit from frequent testing, and collaborative community approaches may help reduce disparities. (Am J Public Health. 2023;113(9):1019–1027. https://doi.org/10.2105/AJPH.2023.307341 )
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. L…
Zitieren
APA
Kimball, A. A., Zhu, W., Yu, L., Tanner, M. R., Iqbal, K., Dominguez, K. L., Shankar, A., Drezner, K., Musgrove, K., Mayes, E., Robinson, W. T., Schumacher, C., Delaney, K. P., Hoover, K. W., & THRIVE Project Team (2023). Benefits of Frequent HIV Testing in the THRIVE Demonstration Project: United States, 2015–2020. American Journal of Public Health. https://doi.org/10.2105/ajph.2023.307341
Vancouver
Kimball AA, Zhu W, Yu L, Tanner MR, Iqbal K, Dominguez KL, et al. Benefits of Frequent HIV Testing in the THRIVE Demonstration Project: United States, 2015–2020. American Journal of Public Health. 2023. doi:10.2105/ajph.2023.307341
BibTeX
@article{Kimball2023,
author = {Kimball, Anne A and Zhu, Weiming and Yu, Lei and Tanner, Mary R and Iqbal, Kashif and Dominguez, Kenneth L and Shankar, Aparna and Drezner, Kate and Musgrove, Karen and Mayes, Eric and Robinson, William T and Schumacher, Christina and Delaney, Kevin P and Hoover, Karen W and THRIVE Project Team, THRIVE Project Team},
title = {Benefits of Frequent HIV Testing in the THRIVE Demonstration Project: United States, 2015–2020},
journal = {American Journal of Public Health},
year = {2023},
doi = {10.2105/ajph.2023.307341}
}
EUVIMED